Clevudine lays claim to the crown in chronic hep B

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1664, 2008-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clevudine for the treatment of chronic hepatitis B virus infection

By Hui Chee-Kin Lau George KK

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 10, 2005-10 ,pp. : 1277-1284

Informa Healthcare

Access to resources Recommend Favorite

Clevudine: a promising therapy for the treatment of chronic hepatitis B

By Asselah Tarik Lada Olivier Moucari Rami Marcellin Patrick

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 12, 2008-12 ,pp. : 1963-1974

Informa Healthcare

Access to resources Recommend Favorite

Should Australia introduce lamivudine for chronic hep B?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 270, 2000-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Clevudine appears to be an effective treatment for patients with hepatitis B infections

Inpharma, Vol. 1, Iss. 1619, 2008-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Hep A vaccination not cost effective for patients with chronic hep C

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 265, 2000-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite